Radnostix, Inc. (INIS)
$0.05+0.00%Close
SELLCRISIS · day 5
Snapshot
- Call
- SELL
- Regime
- CRISISday 5
- Alignment
- ALIGNED BEAR
- 1 week
- -16.7%-15.7% vs SPY
- 1 month
- -28.6%-30.0% vs SPY
- Market cap
- $26.5M
- P/E
- negindustry 19.1
- P/B
- 14.0
- EV/EBITDA
- -16.0
- FCF yield
- -3.5%
- Short % float
- 0.0%
- Days to cover
- 1.0
- Short change
- -84.5%
Signal: Score, Composite, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year
Price & returns: 3 years, 5 years
Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)
Signal evidence
Best ComboVALIDATED · V5
ENTER · HOLD · EXIT · WAITOne next-open action from five signal families, published only when the held-out edge survives 20 bps costs.
Today's action with its out-of-fold profit factor, trade count and family votes.
White ArrowFULL HISTORY
SELL
Directional consensus stays BUY or SELL until the model reverses; trades fill next session open.
Profit factor0.7
Trades192
RegimeFULL HISTORY
CRISIS
BULL or RECOVERY stays invested; BEAR or CRISIS exits at the next session open.
Profit factor and trade count for holding this symbol only in BULL or RECOVERY.
ExhaustionNOW
Whether buyers or sellers are stretched today, the latest release and its strength.
Peers
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company
About
Radnostix, Inc. (INIS). Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals. Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment is respon…
SEC filingsCIK 1038277
Profile
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUS
CEOShahe Bagerdjian
IPOAug 14, 1997
Employees45
Shares outstanding529.1M
Float106.8M
Free float20.2%
Websiteradnostix.com
Key executives
- Shahe BagerdjianPresident,Chief Executive Officer & DirectorUSD 364K
- W. Matthew CoxChief Financial Officer & SecretaryUSD 167K
